The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)–Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts
Open accessAbstract
Fibroblast growth factors (FGF) play a critical role in bone growth and development affecting both chondrogenesis and osteogenesis. During the process of intramembranous ossification, which leads to the formation of the flat bones of the skull, unregulated FGF signaling can produce premature suture closure or craniosynostosis and other craniofacial deformities. Indeed, many human craniosynostosis disorders have been linked to activating mutations in FGF receptors (FGFR) 1 and 2, but the precise effects of FGF on the proliferation, maturation and differentiation of the target osteoblastic cells are still unclear. In this report, we studied the effects of FGF treatment on primary murine calvarial osteoblast, and on OB1, a newly established osteoblastic cell line. We show that FGF signaling has a dual effect on osteoblast proliferation and differentiation. FGFs activate the endogenous FGFRs leading to the formation of a Grb2/FRS2/Shp2 complex and activation of MAP kinase. However, immature osteoblasts respond to FGF treatment with increased proliferation, whereas in differentiating cells FGF does not induce DNA synthesis but causes apoptosis. When either primary or OB1 osteoblasts are induced to differentiate, FGF signaling inhibits expression of alkaline phosphatase, and blocks mineralization. To study the effect of craniosynostosis-linked mutations in osteoblasts, we introduced FGFR2 carrying either the C342Y (Crouzon syndrome) or the S252W (Apert syndrome) mutation in OB1 cells. Both mutations inhibited differentiation, while dramatically inducing apoptosis. Furthermore, we could also show that overexpression of FGF2 in transgenic mice leads to increased apoptosis in their calvaria. These data provide the first biochemical analysis of FGF signaling in osteoblasts, and show that FGF can act as a cell death inducer with distinct effects in proliferating and differentiating osteoblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Receptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Stimulation of Bone Formation in Vitro and in Rodents by Statins
Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,774
Principles of Bone Biology: By Bilezikian, Raisz and Rodan. Academic Press, London, U.K., 1996
Compston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,370
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.
Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N., & Hay, N. (1997) · Genes & Development · doi:10.1101/gad.11.6.701 · Cited by 1,074
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., & Leder, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81069-7 · Cited by 1,070
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I., & Schlessinger, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80252-4 · Cited by 873
fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation.
Yamaguchi, T. P., Harpal, K., Henkemeyer, M., & Rossant, J. (1994) · Genes & Development · doi:10.1101/gad.8.24.3032 · Cited by 778
Murine FGFR-1 is required for early postimplantation growth and axial organization.
Deng, C. X., Wynshaw-Boris, A., Shen, M. M., Daugherty, C., Ornitz, D. M., & Leder, P. (1994) · Genes & Development · doi:10.1101/gad.8.24.3045 · Cited by 741
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 620
Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J. K., & Lonai, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5082 · Cited by 617
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.793 · Cited by 578 · cited 2×
“A major fraction of osteoblasts at bone remodeling sites cannot be accounted for and probably undergo apoptosis (Jilka et al., 1998) and the anabolic effect of PTH is due to its antiapoptotic effect on osteoblasts (Jilka et al., 1999).”
BackgroundCraniosynostosis: genes and mechanisms
Wilkie, A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1647 · Cited by 529
Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
Saxton, T. M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., Feng, G.-S., & Pawson, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2352 · Cited by 480
Kim, H.-J., Rice, D. P. C., Kettunen, P. J., & Thesleff, I. (1998) · Development · doi:10.1242/dev.125.7.1241 · Cited by 412
Integration of FGF and TWIST in calvarial bone and suture development
Rice, D. P. C., Åberg, T., Chan, Y.-S., Tang, Z., J. Kettunen, P., Pakarinen, L., Maxson, R. E., & Thesleff, I. (2000) · Development · doi:10.1242/dev.127.9.1845 · Cited by 407
Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., & Witte, O. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1785 · Cited by 377
Sahni, M., Ambrosetti, D.-C., Mansukhani, A., Gertner, R., Levy, D., & Basilico, C. (1999) · Genes & Development · doi:10.1101/gad.13.11.1361 · Cited by 375
Self-citationIseki, S., Wilkie, A. O. M., & Morriss-Kay, G. M. (1999) · Development · doi:10.1242/dev.126.24.5611 · Cited by 305
Su, W.-C. S., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A., & Fu, X.-Y. (1997) · Nature · doi:10.1038/386288a0 · Cited by 304
Coffin, J. D., Florkiewicz, R. Z., Neumann, J., Mort-Hopkins, T., Dorn, G. W., Lightfoot, P., German, R., Howles, P. N., Kier, A., & O'Toole, B. A. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.12.1861 · Cited by 301
Fibroblast-growth-factor receptor mutations in human skeletal disorders
Muenke, M., & Schell, U. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89088-5 · Cited by 295
Su, J., Muranjan, M., & Sap, J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80234-6 · Cited by 267
Anderson, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1475 · Cited by 247
Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.
(1996) · PubMed Central · Cited by 229
Multiple Extracellular Signals Promote Osteoblast Survival and Apoptosis1
Hill, P. A., Tumber, A., & Meikle, M. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5370 · Cited by 219
FGF signaling in skeletal development
Ornitz, D. M. (1998) · Frontiers in Bioscience · doi:10.2741/a321 · Cited by 215
Functions of fibroblast growth factors in vertebrate development
Goldfarb, M. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00039-1 · Cited by 214
Pitaru, S., Kotev-Emeth, S., Noff, D., Kaffuler, S., & Savion, N. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080804 · Cited by 212
Iseki, S., Wilkie, A. O. M., Heath, J. K., Ishimaru, T., Eto, K., & Morriss-Kay, G. M. (1997) · Development · doi:10.1242/dev.124.17.3375 · Cited by 207
Debiais, F., Hott, M., Graulet, A. M., & Marie, P. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.645 · Cited by 183
Robertson, S. C., Meyer, A. N., Hart, K. C., Galvin, B. D., Webster, M. K., & Donoghue, D. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4567 · Cited by 181
Fibroblast growth factor receptors: lessons from the genes
Burke, D. F., Wilkes, D. C., Blundell, T. L., & Malcolm, S. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01170-5 · Cited by 170
Galvin, B. D., Hart, K. C., Meyer, A. N., Webster, M. K., & Donoghue, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7894 · Cited by 143
Bellosta, P., Zhang, Q. H., Goff, S. P., & Basilico, C. (1997) · Oncogene · doi:10.1038/sj.onc.1201419 · Cited by 143
Self-citationMansukhani, A., Dell’Era, P., Moscatelli, D., Kornbluth, S. A., Hanafusa, H., & Basilico, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3305 · Cited by 142
Self-citationApoptosis in murine calvarial bone and suture development
Rice, D. P. C., Kim, H., & Thesleff, I. (1999) · European Journal Of Oral Sciences · doi:10.1046/j.0909-8836.1999.eos107406.x · Cited by 101
Fragale, A., Tartaglia, M., Bernardini, S., Stasi, A. M. M. D., Rocco, C. D., Velardi, F., Teti, A. M., Battaglia, P. A., & Migliaccio, S. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65401-6 · Cited by 91
Mangasarian, K., Li, Y., Mansukhani, A., & Basilico, C. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199707)172:1<117::aid-jcp13>3.0.co;2-9 · Cited by 87
Self-citationLi, Y., Basilico, C., & Mansukhani, A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7660 · Cited by 71
Self-citationMiho, Y., Kouroku, Y., Fujita, E., Mukasa, T., Urase, K., Kasahara, T., Isoai, A., Momoi, M. Y., & Momoi, T. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400506 · Cited by 58
Cited by
Ornitz, D. M., & Marie, P. J. (2002) · Genes & Development · doi:10.1101/gad.990702 · Cited by 905
Mechanisms underlying differential responses to FGF signaling
Dailey, L., Ambrosetti, D., Mansukhani, A., & Basilico, C. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.007 · Cited by 649
Self-citationCranial sutures as intramembranous bone growth sites
Opperman, L. A. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1073>3.0.co;2-f · Cited by 645
Functions and regulations of fibroblast growth factor signaling during embryonic development
Thisse, B., & Thisse, C. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.09.011 · Cited by 497
Ohbayashi, N., Shibayama, M., Kurotaki, Y., Imanishi, M., Fujimori, T., Itoh, N., & Takada, S. (2002) · Genes & Development · doi:10.1101/gad.965702 · Cited by 482
Metadata
- Authors
- Mansukhani, A., Bellosta, P., Sahni, M., & Basilico, C.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2000-06-12
- Volume
- 149
- Issue
- 6
- Pages
- 1297-1308
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2067872631
- Cited by
- 295
- References
- 42
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.